Scientific Advisory Team

The Scientific Advisory Team at Mitokinin is comprised of leading experts in neuroscience, chemistry, and pharmacology who provide strategic guidance on research initiatives and therapeutic development. Their expertise drives the advancement of small molecule therapeutics targeting PINK1, ensuring that the company's efforts align with the latest scientific insights and regulatory standards. This team plays a crucial role in validating the efficacy and safety of treatments aimed at addressing neurodegenerative diseases, ultimately supporting Mitokinin’s mission to deliver innovative solutions in healthcare.